問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
Find Hospital
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
吳造中
下載
2023-10-02 - 2030-09-30
Condition/Disease
Test Drug
Participate Sites10Sites
Recruiting10Sites
2023-07-01 - 2026-01-31
Participate Sites7Sites
Recruiting7Sites
2024-05-01 - 2029-12-31
2023-06-20 - 2026-06-30
Participate Sites4Sites
Recruiting4Sites
2024-06-01 - 2027-12-31
2021-05-18 - 2026-08-21
2018-10-24 - 2024-03-31
Obesity
Semaglutide B 3.0 mg/mL PDS290 or Semaglutide placebo
Participate Sites6Sites
Terminated2Sites
Division of Cardiovascular Diseases
全部
